192 related articles for article (PubMed ID: 26694172)
1. Cytoplasmic Drosha Is Aberrant in Precancerous Lesions of Gastric Carcinoma and Its Loss Predicts Worse Outcome for Gastric Cancer Patients.
Zhang H; Hou Y; Xu L; Zeng Z; Wen S; Du YE; Sun K; Yin J; Lang L; Tang X; Liu M
Dig Dis Sci; 2016 Apr; 61(4):1080-90. PubMed ID: 26694172
[TBL] [Abstract][Full Text] [Related]
2. Paradoxical expression of maspin in gastric carcinomas: correlation with carcinogenesis and progression.
Yu M; Zheng H; Tsuneyama K; Takahashi H; Nomoto K; Xu H; Takano Y
Hum Pathol; 2007 Aug; 38(8):1248-55. PubMed ID: 17490717
[TBL] [Abstract][Full Text] [Related]
3. Evidence that gastric pit dysplasia-like atypia is a neoplastic precursor lesion.
Agoston AT; Odze RD
Hum Pathol; 2014 Mar; 45(3):446-55. PubMed ID: 24529328
[TBL] [Abstract][Full Text] [Related]
4. Nuclear or cytoplasmic localization of Bag-1 distinctly correlates with pathologic behavior and outcome of gastric carcinomas.
Zheng HC; Xu XY; Xing YN; Wei ZL; Takahashi H; Masuda S; Takano Y
Hum Pathol; 2010 May; 41(5):724-36. PubMed ID: 20096920
[TBL] [Abstract][Full Text] [Related]
5. [Expression of intestine-specific transcription factor CDX2 in different subtypes of intestinal metaplasia and gastric carcinoma].
Liu GS; Gong J; Cheng P; Zhang J; Chang Y; Qiang L
Ai Zheng; 2006 Feb; 25(2):185-9. PubMed ID: 16480583
[TBL] [Abstract][Full Text] [Related]
6. Expression of trefoil peptides (TFF1, TFF2, and TFF3) in gastric carcinomas, intestinal metaplasia, and non-neoplastic gastric tissues.
Leung WK; Yu J; Chan FK; To KF; Chan MW; Ebert MP; Ng EK; Chung SC; Malfertheiner P; Sung JJ
J Pathol; 2002 Aug; 197(5):582-8. PubMed ID: 12210076
[TBL] [Abstract][Full Text] [Related]
7. Bax and Bcl-2 protein expression in gastric precancerous lesions: immunohistochemical study.
Anagnostopoulos GK; Stefanou D; Arkoumani E; Sakorafas G; Pavlakis G; Arvanitidis D; Tsianos E; Agnantis NJ
J Gastroenterol Hepatol; 2005 Nov; 20(11):1674-8. PubMed ID: 16246184
[TBL] [Abstract][Full Text] [Related]
8. CEACAM5 has different expression patterns in gastric non-neoplastic and neoplastic lesions and cytoplasmic staining is a marker for evaluation of tumor progression in gastric adenocarcinoma.
Liu JN; Wang HB; Zhou CC; Hu SY
Pathol Res Pract; 2014 Oct; 210(10):686-93. PubMed ID: 25042385
[TBL] [Abstract][Full Text] [Related]
9. Frequent translocalization of beta-catenin in gastric cancers and its relevance to tumor progression.
Cheng XX; Sun Y; Chen XY; Zhang KL; Kong QY; Liu J; Li H
Oncol Rep; 2004 Jun; 11(6):1201-7. PubMed ID: 15138556
[TBL] [Abstract][Full Text] [Related]
10. Dynamic expression of CEACAM7 in precursor lesions of gastric carcinoma and its prognostic value in combination with CEA.
Zhou J; Zhang L; Gu Y; Li K; Nie Y; Fan D; Feng Y
World J Surg Oncol; 2011 Dec; 9():172. PubMed ID: 22195770
[TBL] [Abstract][Full Text] [Related]
11. [Precancerous conditions in gastric cancer (II): relationship between atrophic gastritis-intestinal metaplasia-gastric dysplasia-gastric carcinoma].
Martínez Díaz FJ; Canteras Jordana M; Ortuño Pacheco G
Rev Esp Enferm Dig; 1991 Jul; 80(1):17-21. PubMed ID: 1931240
[TBL] [Abstract][Full Text] [Related]
12. Clinical Significance of Myeloid Zinc Finger 1 Expression in the Progression of Gastric Tumourigenesis.
Li GQ; He Q; Yang L; Wang SB; Yu DD; He YQ; Hu J; Pan YM; Wu Y
Cell Physiol Biochem; 2017; 44(3):1242-1250. PubMed ID: 29179204
[TBL] [Abstract][Full Text] [Related]
13. Expression of claudin-2 in the multistage process of gastric carcinogenesis.
Song X; Li X; Tang Y; Chen H; Wong B; Wang J; Chen M
Histol Histopathol; 2008 Jun; 23(6):673-82. PubMed ID: 18366005
[TBL] [Abstract][Full Text] [Related]
14. The role of Reg IV gene and its encoding product in gastric carcinogenesis.
Zheng HC; Xu XY; Yu M; Takahashi H; Masuda S; Takano Y
Hum Pathol; 2010 Jan; 41(1):59-69. PubMed ID: 19740514
[TBL] [Abstract][Full Text] [Related]
15. Tumor suppresser gene p53 expression in premalignant lesions and gastric carcinoma - prognostic value.
Vukobrat-Bijedić Z; Radović S; Husić-Selimović A; Gornjaković S
Bosn J Basic Med Sci; 2007 Feb; 7(1):7-10. PubMed ID: 17489760
[TBL] [Abstract][Full Text] [Related]
16. Identification of CEACAM5 as a Biomarker for Prewarning and Prognosis in Gastric Cancer.
Zhou J; Fan X; Chen N; Zhou F; Dong J; Nie Y; Fan D
J Histochem Cytochem; 2015 Dec; 63(12):922-30. PubMed ID: 26374829
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical expression of the human sodium/iodide symporter distinguishes malignant from benign gastric lesions.
Farnedi A; Eusebi LH; Poli F; Foschini MP
Int J Surg Pathol; 2009 Aug; 17(4):327-34. PubMed ID: 19124451
[TBL] [Abstract][Full Text] [Related]
18. [Down-regulation of Caspase-3 expression in precancerous lesions and its relation to gastric carcinogenesis].
Yang L; Wu DY; Xin Y
Zhonghua Zhong Liu Za Zhi; 2006 May; 28(5):357-60. PubMed ID: 17045000
[TBL] [Abstract][Full Text] [Related]
19. The hippo pathway in human upper gastrointestinal dysplasia and carcinoma: a novel oncogenic pathway.
Lam-Himlin DM; Daniels JA; Gayyed MF; Dong J; Maitra A; Pan D; Montgomery EA; Anders RA
Int J Gastrointest Cancer; 2006; 37(4):103-9. PubMed ID: 18175224
[TBL] [Abstract][Full Text] [Related]
20. The microRNA maturation regulator Drosha is an independent predictor of outcome in breast cancer patients.
Khoshnaw SM; Rakha EA; Abdel-Fatah T; Nolan CC; Hodi Z; Macmillan RD; Ellis IO; Green AR
Breast Cancer Res Treat; 2013 Jan; 137(1):139-53. PubMed ID: 23225145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
